Newbridge Financial Services Group’s Greenwich LifeSciences GLSI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $19K | Buy |
2,100
+800
| +62% | +$7.26K | ﹤0.01% | 739 |
|
|
2025
Q1 | $12.4K | Hold |
1,300
| – | – | ﹤0.01% | 641 |
|
|
2024
Q4 | $14.6K | Buy |
+1,300
| New | +$14.6K | ﹤0.01% | 670 |
|
|
2024
Q3 | – | Sell |
-1,900
| Closed | -$32.8K | – | 824 |
|
|
2024
Q2 | $32.8K | Buy |
1,900
+400
| +27% | +$6.9K | 0.01% | 476 |
|
|
2024
Q1 | $29.9K | Hold |
1,500
| – | – | 0.01% | 517 |
|
|
2023
Q4 | $15.8K | Hold |
1,500
| – | – | 0.01% | 638 |
|
|
2023
Q3 | $13.3K | Hold |
1,500
| – | – | 0.01% | 745 |
|
|
2023
Q2 | $14.5K | Buy |
1,500
+600
| +67% | +$5.79K | 0.01% | 798 |
|
|
2023
Q1 | $12.4K | Buy |
900
+400
| +80% | +$5.52K | 0.01% | 870 |
|
|
2022
Q4 | $7.6K | Hold |
500
| – | – | ﹤0.01% | 977 |
|
|
2022
Q3 | $5K | Hold |
500
| – | – | ﹤0.01% | 1041 |
|
|
2022
Q2 | $4K | Hold |
500
| – | – | ﹤0.01% | 1051 |
|
|
2022
Q1 | $10K | Hold |
500
| – | – | ﹤0.01% | 937 |
|
|
2021
Q4 | $12K | Hold |
500
| – | – | 0.01% | 875 |
|
|
2021
Q3 | $20K | Buy |
+500
| New | +$20K | 0.01% | 662 |
|